Group One Trading
GMAB icon

Group One Trading’s Genmab GMAB Stock Holding History

Group One Trading’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Sell
8,846
-14,506
-62% -$386K ﹤0.01% 4136
2026
Q1 		$627K Sell
23,352
-6,147
-21% -$184K ﹤0.01% 3136
2025
Q4 		$909K Buy
+29,499
New +$919K ﹤0.01% 2977
2025
Q3 		– Sell
-8
Closed -$195 – 8653
2025
Q2 		$165 Buy
+8
New +$164 ﹤0.01% 7759
2020
Q1 		– Sell
-100
Closed -$2K – 5437
2019
Q4 		$2K Buy
+100
New +$2.18K ﹤0.01% 4897

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Group One Trading's GMAB Position: Q2 2026 in Review

Group One Trading reduced its Genmab (GMAB) stake by 62% in Q2 2026, selling an estimated $386K and leaving 8,846 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #4136.

Group One Trading first reported a position in GMAB in Q4 2019 and has held it in 5 quarters since. The position peaked at $909K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Group One Trading held 8,846 shares of Genmab worth $243K as of Q2 2026.
  • Group One Trading sold 14,506 Genmab shares in Q2 2026, an estimated $386K.
  • Genmab made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4136 holding.
  • Group One Trading first reported a position in Genmab in Q4 2019 and has held it in 5 quarters since.
  • Group One Trading's Genmab position peaked at $909K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.